Dual Path Platform

A tecnologia DPP® da Chembio difere dos testes clássicos de fluxo lateral por operar de maneira semelhante aos testes ELISA, não sendo sensível ao “Efeito Gancho”.

DPP® Technological Advantages:

  • Enhanced multiplex capability up to 8 biomarkers with results in minutes
  • Significantly increased analytical and clinical sensitivity
  • Ability to effectively resolve normal aggregation/agglutination migratory issues, a common concern in lateral flow assays with large particle analytes (e.g., bacteria)
  • Adaptable to multiple sample types such as fingerstick blood, oral fluid, venous whole blood, serum and plasma